Sick Building Syndrome: Symptoms, Causes, and What to Do Next

A respiratory therapist in a public AMA described the sick-building problem in miniature: several people felt better after days away from a clinic and worse again within an hour of returning. The building had repeated roof leaks plus visible yellow mold above ceiling tiles. The report still looked reassuring, with low mold spore counts and no mycotoxins detected in the air sample. That public example doesn't prove mold caused anything. It does show why a normal-looking report may not feel like the final answer when your symptoms improve away from the building and return when you go back inside.

Sick building syndrome is the name for that unsettled middle. EPA's sick building syndrome fact sheet describes SBS as acute health or comfort effects that seem linked to time spent in a building. No specific illness or cause has been identified. EPA's office indoor air guide adds the key caution: those symptoms may or may not be related to poor indoor air quality.

So SBS is a pattern before diagnosis. Feeling better away from a building and worse inside can justify documentation and a closer look. It doesn't diagnose mold toxicity, Chronic Inflammatory Response Syndrome (CIRS), asthma, hypersensitivity pneumonitis, legal responsibility, workplace safety, or personal health risk.

What the pattern can show

A building-linked symptom pattern can tell you that timing deserves attention. Write down when symptoms appear, when they ease, which rooms or zones are involved, whether other people notice a similar pattern, and what building clues you see, such as stains, odors, leaks, visible growth, humidity, HVAC changes, or recent renovations.

The pattern can't identify the cause by itself. EPA lists complaints such as irritated eyes, nose, or throat, sneezing, nasal symptoms, fatigue, headache, dizziness, nausea, irritability, and forgetfulness in office indoor-air situations, but the same guidance names other contributors, including lighting, noise, vibration, thermal discomfort, stress, allergies, infection, and non-building health issues. That is why SBS can be useful without being conclusive.

SBS is also different from building-related illness. EPA's fact sheet contrasts SBS with building-related illness, where the symptoms can be clinically defined and have clearly identifiable causes. A group of occupants with headaches, burning eyes, or fatigue may have a real building-linked complaint, but chest tightness, shortness of breath, fever, worsening asthma, severe symptoms, or symptoms that persist outside the building should shift the question toward medical evaluation.

For more symptom context, MoldCo's guide to mold exposure symptoms can help you compare patterns. Keep the same rule in mind there too: symptoms can point you toward better questions, but they don't prove the cause by themselves.

Where mold fits

Mold can fit the sick-building picture when there is visible growth, musty odor, condensation, repeated leaks, wet materials, water under floors, or a history of water intrusion. WHO's indoor air guideline summary says persistent dampness and microbial growth should be avoided or minimized, and it treats visible mold, moldy odor, condensation, and water-damage history as indicators worth investigating.

But mold is one possible building-side factor, not the default answer to every SBS pattern. Ventilation problems, outdoor air intake, cleaning products, office equipment, furnishings, combustion sources, temperature, humidity, noise, and stress can all contribute to complaints. MoldCo's guide to indoor air quality and mold goes deeper on how moisture and air-quality questions fit together.

The safest mold claim is also the most useful one: dampness and mold deserve attention because they are associated with real health effects, especially respiratory and allergic ones. CDC/NIOSH links damp buildings and workplace mold with respiratory symptoms, asthma problems, allergic rhinitis, hypersensitivity pneumonitis in susceptible people, and eczema. EPA's mold health page describes allergic reactions, asthma attacks in people with asthma who are allergic to mold, and irritation of the eyes, skin, nose, throat, and lungs. WHO's evidence review supports associations between damp indoor environments and outcomes such as upper respiratory symptoms, cough, wheeze, and asthma symptoms in sensitized people, while keeping the specific causal agents more limited.

That means mold deserves a place in the investigation. It does not mean every SBS pattern is mold illness.

Why a normal air test may not settle it

A low-spore or normal short-term air sample can be one data point. It is not the same as proving a building is safe for every person or ruling out every moisture problem.

CDC/NIOSH says there are no health-based standards for mold or other biological agents in indoor air. Routine air sampling is not recommended for many building air-quality evaluations, and short-term spore counts or culture results can't be interpreted as health-risk measurements. EPA's mold sampling guidance adds that visible mold usually does not need sampling just to prove mold exists, and no EPA or other federal limits have been set for airborne mold or mold spores.

The practical takeaway is not that air tests are useless. It is to ask what question the test answered. A short-term air sample may help describe what was detected during one window. It may not answer whether moisture remains hidden in a wall, whether settled dust in a home contains water-damage-associated species, whether a remediation scope is adequate, whether a workplace is safe, or whether your symptoms have a medical cause. MoldCo's blood versus environmental testing guide explains why building-side and body-side tests answer different questions.

Match the next step to the open question

If the open question is the building, keep documenting the timing, rooms, odors, leaks, stains, visible growth, HVAC patterns, humidity, and whether multiple people are affected. A qualified building or indoor-air professional may be the right fit when the question involves source finding, inspection, remediation scope, workplace safety, rental documentation, insurance, or legal proof. MoldCo does not inspect buildings, remediate mold, certify workplaces, write remediation scopes, or provide legal documentation.

If the open question is your health, especially if symptoms are severe, persistent, respiratory, chest-related, fever-like, neurologic, unusual, or not limited to one building, talk with a healthcare provider. This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your healthcare provider about your specific situation.

If the open question is your own home or personal space, MoldCo's $199 Mold Home Test Kit is a HERTSMI-2 settled-dust test that ships to the home, is available in all 50 U.S. states, tests five mold species highly associated with water damage, and returns results in 1 to 2 weeks, but it does not diagnose SBS, CIRS, allergy, asthma, mold toxicity, hypersensitivity pneumonitis, or personal health risk, and it does not replace inspection, remediation, workplace certification, or legal proof.

If the open question is whether your adult symptom-plus-exposure history is worth evaluating for mold-related illness, MoldCo's questionnaire can help organize that next step, but it is not urgent care, pediatric care, workplace documentation, legal proof, or a diagnosis.

That is the better way to think about sick building syndrome: not as a verdict, and not as something to ignore. It is a signal to ask the next question more carefully.

Medical disclaimer

Any health-related claims made on this site have not been evaluated by the Food and Drug Administration (FDA). The information provided on this site is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. MoldCo assumes no responsibility or liability for any errors or omissions in the content of the references, nor for any actions taken in reliance thereon.